Clinical Trial Update: A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating safety and effectiveness of liquid Certolizumab Pegol for active rheumatoid arthritis and prevention of joint damage; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Liquid Certolizumab Pegol (certolizumab pegol)

Snippet

Sponsor: UCB Pharma | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-03-07